DE1692043C3 - Rhinopneumonitis-Vaccine und Verfahren zu deren Herstellung - Google Patents

Rhinopneumonitis-Vaccine und Verfahren zu deren Herstellung

Info

Publication number
DE1692043C3
DE1692043C3 DE1692043A DEB0096943A DE1692043C3 DE 1692043 C3 DE1692043 C3 DE 1692043C3 DE 1692043 A DE1692043 A DE 1692043A DE B0096943 A DEB0096943 A DE B0096943A DE 1692043 C3 DE1692043 C3 DE 1692043C3
Authority
DE
Germany
Prior art keywords
virus
rhinopneumonitis
vaccine
culture
mares
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE1692043A
Other languages
German (de)
English (en)
Other versions
DE1692043A1 (de
DE1692043B2 (de
Inventor
Anton Prof. Dr. 8000 Muenchen Mayr
Jan Dr. 8000 Muenchen Pette (Verstorben)
Klaus Dr. 3000 Hannover Petzoldt
Kurt Prof. Dr. 3000 Hannover Wagener
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Priority to DE1692043A priority Critical patent/DE1692043C3/de
Priority to FI690547A priority patent/FI45766C/fi
Priority to NL696903064A priority patent/NL149378B/xx
Priority to IE268/69A priority patent/IE32655B1/xx
Priority to SE02943/69A priority patent/SE348495B/xx
Priority to NO00919/69A priority patent/NO129095B/no
Priority to CA044,687A priority patent/CA942190A/en
Priority to DK121969AA priority patent/DK122823B/da
Priority to BE729460D priority patent/BE729460A/xx
Priority to AT222369A priority patent/AT286497B/de
Priority to FR6906217A priority patent/FR2003343A1/fr
Priority to GB02004/69A priority patent/GB1263181A/en
Publication of DE1692043A1 publication Critical patent/DE1692043A1/de
Priority to US00220456A priority patent/US3725542A/en
Priority to NL767602975A priority patent/NL154938B/xx
Publication of DE1692043B2 publication Critical patent/DE1692043B2/de
Application granted granted Critical
Publication of DE1692043C3 publication Critical patent/DE1692043C3/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/27—Equine rhinopneumonitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/82—Viral vaccine for equine species, e.g. horses

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE1692043A 1968-03-06 1968-03-06 Rhinopneumonitis-Vaccine und Verfahren zu deren Herstellung Expired DE1692043C3 (de)

Priority Applications (14)

Application Number Priority Date Filing Date Title
DE1692043A DE1692043C3 (de) 1968-03-06 1968-03-06 Rhinopneumonitis-Vaccine und Verfahren zu deren Herstellung
FI690547A FI45766C (fi) 1968-03-06 1969-02-20 Menetelmä rokotteen valmistamiseksi hevosten rhinopneumonitisvirusinfe ktiota vastaan.
NL696903064A NL149378B (nl) 1968-03-06 1969-02-27 Werkwijze voor het bereiden van een rhinopneumonitisvaccin, alsmede ampul met aldus verkregen vaccin.
IE268/69A IE32655B1 (en) 1968-03-06 1969-02-28 Rhinopneumonitis vaccine and process for its preparation
SE02943/69A SE348495B (cg-RX-API-DMAC7.html) 1968-03-06 1969-03-04
CA044,687A CA942190A (en) 1968-03-06 1969-03-05 Vaccine against rhinopneumonitis and process for preparing it
DK121969AA DK122823B (da) 1968-03-06 1969-03-05 Fremgangsmåde til fremstilling af en vaccine imod Rhinopneumonitisvirusinfektion på heste.
NO00919/69A NO129095B (cg-RX-API-DMAC7.html) 1968-03-06 1969-03-05
BE729460D BE729460A (cg-RX-API-DMAC7.html) 1968-03-06 1969-03-06
AT222369A AT286497B (de) 1968-03-06 1969-03-06 Verfahren zur Herstellung einer Vaccine
FR6906217A FR2003343A1 (cg-RX-API-DMAC7.html) 1968-03-06 1969-03-06
GB02004/69A GB1263181A (en) 1968-03-06 1969-03-06 Rhinopneumonitis vaccine and process for its preparation
US00220456A US3725542A (en) 1968-03-06 1972-01-24 Intramuscular vaccination program and vaccine against rhinopneumonitis and process for preparing it
NL767602975A NL154938B (nl) 1968-03-06 1976-03-22 Werkwijze voor het bereiden van een rhinopneumonitis vaccin, alsmede ampul met aldus verkregen vaccin.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1692043A DE1692043C3 (de) 1968-03-06 1968-03-06 Rhinopneumonitis-Vaccine und Verfahren zu deren Herstellung

Publications (3)

Publication Number Publication Date
DE1692043A1 DE1692043A1 (de) 1971-07-29
DE1692043B2 DE1692043B2 (de) 1978-08-10
DE1692043C3 true DE1692043C3 (de) 1979-04-12

Family

ID=6989015

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1692043A Expired DE1692043C3 (de) 1968-03-06 1968-03-06 Rhinopneumonitis-Vaccine und Verfahren zu deren Herstellung

Country Status (13)

Country Link
US (1) US3725542A (cg-RX-API-DMAC7.html)
AT (1) AT286497B (cg-RX-API-DMAC7.html)
BE (1) BE729460A (cg-RX-API-DMAC7.html)
CA (1) CA942190A (cg-RX-API-DMAC7.html)
DE (1) DE1692043C3 (cg-RX-API-DMAC7.html)
DK (1) DK122823B (cg-RX-API-DMAC7.html)
FI (1) FI45766C (cg-RX-API-DMAC7.html)
FR (1) FR2003343A1 (cg-RX-API-DMAC7.html)
GB (1) GB1263181A (cg-RX-API-DMAC7.html)
IE (1) IE32655B1 (cg-RX-API-DMAC7.html)
NL (1) NL149378B (cg-RX-API-DMAC7.html)
NO (1) NO129095B (cg-RX-API-DMAC7.html)
SE (1) SE348495B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110433A (en) * 1976-04-23 1978-08-29 Philips Roxane, Inc. Equine rhinopneumonitis virus
US4083958A (en) * 1976-09-13 1978-04-11 The University Of Kentucky Research Foundation Inactivated equine rhinopneumonitis virus vaccine and use thereof
US4225582A (en) * 1979-03-08 1980-09-30 The University Of Illinois Foundation Vaccine for equine rhinopneumonitis

Also Published As

Publication number Publication date
FI45766C (fi) 1972-09-11
FI45766B (cg-RX-API-DMAC7.html) 1972-05-31
NL6903064A (cg-RX-API-DMAC7.html) 1969-09-09
DK122823B (da) 1972-04-17
NL149378B (nl) 1976-05-17
FR2003343A1 (cg-RX-API-DMAC7.html) 1969-11-07
US3725542A (en) 1973-04-03
IE32655L (en) 1969-09-06
DE1692043A1 (de) 1971-07-29
NO129095B (cg-RX-API-DMAC7.html) 1974-02-25
BE729460A (cg-RX-API-DMAC7.html) 1969-09-08
GB1263181A (en) 1972-02-09
SE348495B (cg-RX-API-DMAC7.html) 1972-09-04
DE1692043B2 (de) 1978-08-10
AT286497B (de) 1970-12-10
IE32655B1 (en) 1973-10-17
CA942190A (en) 1974-02-19

Similar Documents

Publication Publication Date Title
DE69327307T2 (de) Herstellung von antigenen und impfstoffen vom mysterie-disease-virus, antigene und erworbene impfstoffe zur verhinderung dieser krankheit
DE2516274C2 (de) Verfahren zum Herstellen eines abgeschwächten Zytomegalie-Virus-Impfstoffes
DE2717919A1 (de) Verfahren zur herstellung eines pferde-rhinopneumonievakzins und durch dieses verfahren hergestelltes vakzin
DE1617940A1 (de) Zellstaemme
CH622702A5 (cg-RX-API-DMAC7.html)
DE1692043C3 (de) Rhinopneumonitis-Vaccine und Verfahren zu deren Herstellung
CH658192A5 (de) Tollwut-impfstoff und verfahren zu seiner herstellung.
DE2816942C2 (de) Impfstoff gegen Rhinitis atrophicans beim Schwein
DE3784397T2 (de) Lebendvaccine fuer ansteckungskrankheiten von kueken.
DE1950774A1 (de) Heteroploide Zellinien
DE2602478A1 (de) Verfahren zur herstellung einer vaccine gegen die panleukopenie der katze
DE2057544C3 (de) Impfstoff gegen ein neonatales Kälberdiarrhoevirus, Verfahren zu seiner Herstellung und seine Verwendung
CH618091A5 (en) Method for the attenuation of virulent feline rhinotracheitis virus and use of this virus for the production of a vaccine
DE2702634A1 (de) Verfahren zur herstellung einer vaccine gegen die panleukopenie der katze
DE1253412B (de) Verfahren zur Gewinnung eines Impfstoffes gegen infektioese Schweinegastroenteritis
DE2162013C3 (de) Tollwut-Lebendimpfstoff, Verfahren zu seiner Herstellung nd seine Verwendung bei der Bekämpfung von Tollwut
AT248791B (de) Verfahren zum Schützen von Hunden vor Staupe
DE1792356C2 (de) Staupe-Kombinationsvaccinen und Verfahren zu ihrer Herstellung
AT234902B (de) Verfahren zur Herstellung einer Vaccine gegen Staupe
DE2225548A1 (de) Intravenoes vertraegliche staupe- und hepatitisvaccine
DE3008224A1 (de) Impfstoff fuer pferde
DE2121237C3 (de) Verwendung einer Zellinie zur Züchtung von Viren
DE1021128B (de) Verfahren zur Herstellung eines Impfstoffes gegen die Rhinotracheitis der Rinder
DE2517550C3 (de) Verfahren zum Herstellen eines Lebend-Impfstoffs zum Immunisieren von fleischfressenden Tieren gegen Staupe
DE1492083A1 (de) Verfahren zum Auswaehlen eines Virus oder sonstigen Organismus mit der Faehigkeit,in einem Tier Schutzwiderstand gegen einen mit dem Virus oder Organismus immunologisch nicht verwandten Krankheitserreger hervorzurufen

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)